Immutep Limited (ASX:IMM)
Australia · Delayed Price · Currency is AUD 0.2650
+0.0100 (3.92%)
Aug 15, 2025, 4:10 PM AEST
Immutep Market Cap
Immutep has a market cap or net worth of 388.98 million as of August 15, 2025. Its market cap has decreased by -9.23% in one year.
Market Cap
388.98M
Enterprise Value
231.41M
Revenue
4.88M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.27
Market Cap Chart
Since August 29, 1996, Immutep's market cap has increased from 3.66M to 388.98M, an increase of 10,519.38%. That is a compound annual growth rate of 17.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 388.98M | -26.78% |
| Dec 31, 2024 | 531.29M | 29.54% |
| Dec 29, 2023 | 410.15M | 69.62% |
| Dec 30, 2022 | 241.81M | -42.22% |
| Dec 31, 2021 | 418.52M | 55.46% |
| Dec 31, 2020 | 269.22M | 166.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 130.92B |
| Pro Medicus | 32.75B |
| Cochlear | 20.21B |
| Sonic Healthcare | 13.99B |
| Ramsay Health Care | 9.01B |
| Telix Pharmaceuticals | 5.92B |
| Ansell | 4.61B |
| Mesoblast | 3.21B |